Page last updated: 2024-11-03

proadifen and Leukopenia

proadifen has been researched along with Leukopenia in 3 studies

Proadifen: An inhibitor of drug metabolism and CYTOCHROME P-450 ENZYME SYSTEM activity.

Leukopenia: A decrease in the number of LEUKOCYTES in a blood sample below the normal range (LEUKOCYTE COUNT less than 4000).

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19903 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gill, DP1
Kempen, RR1
Nash, JB1
Ellis, S1
Hayes, FD1
Short, RD1
Gibson, JE1
Solymoss, B1
Somogyi, A1
Kovács, K1

Other Studies

3 other studies available for proadifen and Leukopenia

ArticleYear
Modifications of benzene myelotoxicity and metabolism by phenobarbital, SKF-525A and 3-methylcholanthrene.
    Life sciences, 1979, Nov-05, Volume: 25, Issue:19

    Topics: Animals; Benzene; Leukocytosis; Leukopenia; Male; Methylcholanthrene; Phenobarbital; Phenols; Proadi

1979
A correlation between cyclophosphamide induced leukopenia in mice and the presence of alkylating metabolites.
    Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.), 1972, Volume: 139, Issue:2

    Topics: Alkylating Agents; Animals; Cyclophosphamide; Female; In Vitro Techniques; Kinetics; Leukocyte Count

1972
Effect of spironolactone and proadifen on 7,12-dimethylbenz(a)anthracene-induced haematologic changes.
    Haematologia, 1971, Volume: 5, Issue:1

    Topics: Animals; Benz(a)Anthracenes; Blood Cells; Blood Platelets; Bone Marrow Examination; Drug Antagonism;

1971